Ferroptosis promotes aortic stenosis through 5-lipoxygenase

The authors investigate the role of ferroptosis, specifically through the arachidonate 5-lipoxygenase (ALOX5) pathway, in the progression of calcific aortic valve disease (CAVD) leading to aortic stenosis. They demonstrate that intra-leaflet hemorrhage and lipid peroxidation are key contributors to valvular ferroptosis, and targeting the ALOX5-ACSL4 axis may offer a novel therapeutic approach to mitigate valve thickening and dysfunction. Their findings suggest that ALOX5 inhibition could serve as a promising clinical intervention for patients with CAVD.